FDA Makes Access to Clozapine Easier for Patients With Schizophrenia

Follow Drugslib on

Medically reviewed by Drugs.com.

By Stephanie Brown HealthDay Reporter

FRIDAY, Feb. 28, 2025 -- The U.S. Food and Drug Administration has removed one hurdle faced by patients with schizophrenia when filling prescriptions for the antipsychotic medication clozapine.

The agency has eliminated the need for pharmacists to verify a patient's white blood cell count before dispensing the medication. Neutropenia is a rare side effect of clozapine, and severe cases can be life-threatening. The blood test was a necessary part of a regimen known as risk evaluation and mitigation strategies, or REMS. The regimen required patients to undergo weekly, biweekly, and monthly blood tests, the results of which were uploaded to a database accessible by pharmacists.

"Although the risk of severe neutropenia with clozapine still exists, FDA has determined that the REMS program for clozapine is no longer necessary to ensure the benefits of the medicine outweigh that risk," the agency said in a medication update. "FDA still recommends that prescribers monitor patients' absolute neutrophil count according to the monitoring frequencies described in the prescribing information."

Long considered an undue burden on clinicians, patients, and pharmacists wanting to use clozapine to treat schizophrenia, the removal of this regulation was met with relief. According to Frederick C. Nucifora, M.D., director of the Adult Schizophrenia Clinic at the Johns Hopkins School of Medicine, as many as 30 percent of patients with schizophrenia would benefit from clozapine.

"I have had many patients who were doing terribly, who struggled to function outside the hospital, and cycled through many medications," Nucifora told The New York Times. "If they go on clozapine, they really tend to not be hospitalized again. I've had people go on to finish college and work. It's quite remarkable."

The New York Times Article

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2025-03-01 18:00

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords